Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02615197 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT02615197 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 35 participants.
The verdict
NCT02615197, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The present project has two primary aims: (1) to examine the effectiveness of a multi-component implementation strategy in improving adoption and adherence to the Dialectical Behavior Therapy Prolonged Exposure (DBT PE) protocol, and (2) to evaluate the feasibility, acceptability, and effectiveness of the DBT PE protocol in a sample of individuals receiving DBT in public mental health agencies. This study uses a hybrid type 2 effectiveness-implementation design to simultaneously test the clinical effectiveness of DBT + DBT PE and to evaluate an adaptive, multi-component implementation strategy. The effectiveness trial will use a quasi-experimental, controlled design to evaluate outcomes among DBT clients with PTSD who do versus do not receive the DBT PE protocol and outcomes will be benchmarked to those obtained in research settings.
Interventions
- BEHAVIORAL Dialectical Behavior Therapy
- BEHAVIORAL Dialectical Behavior Therapy Prolonged Exposure protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02615197
The ClinicalTrials.gov registry entry for NCT02615197 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dialectical Behavior Therapy is the first listed.
NCT02615197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02615197 about?
NCT02615197 is a clinical study titled "Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients". The present project has two primary aims: (1) to examine the effectiveness of a multi-component implementation strategy in improving adoption and adherence to the Dialectical Behavior Therapy Prolonged Exposure (DBT PE) protocol, and (2) to evaluate the feasibility, acceptability, and effectiveness ...
What is the current status of trial NCT02615197?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2016-02. Estimated completion is 2019-03.
What interventions are being tested in trial NCT02615197?
The interventions under investigation include: Dialectical Behavior Therapy (BEHAVIORAL), Dialectical Behavior Therapy Prolonged Exposure protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT02615197?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.